Abstract
An in vivo study of the effect of Isoprinosine onEchinococcus multilocularis andE. granulosus metacestodes (Cestoda) was performed. Short- and longterm treatments with different doses were tested in experimental hosts: jirds forE. multilocularis and mice forE. granulosus. Modifications in the weight of animals as well as macroscopical and ultrastructural aspects were registered for each animal group. The results obtained showed a considerable ultrastructural alteration inE. multilocularis metacestodes after short-term treatment with the highest dose, and the tissue transplants were negative. InE. granulosus cysts the ultrastructural damage was also very important and its severity increased as the dose was raised. For the two parasites, the macroscopical aspect and weight of the lesions were profoundly changed.
Similar content being viewed by others
References
Akinoglu A, Demiryurek H, Guzel L (1991) Alveolar hydatid disease of the liver: a report on thirty-nine surgical cases in eastern Anatolia, Turkey. Am J Trop Med Hyg 45:182–189
Ammann RW, Hirsbrunner R, Cotting J, Steiger U, Jacquier P, Eckert J (1990) Recurrence rate after discontinuation of longterm mebendazole therapy in alveolar echinococcosis (preliminary results). Am J Trop Med Hyg 43:506–515
Bartoloni C, Tricerri A, Guidi L, Gambassi G (1992) The efficacy of chemotherapy with mebendazole in human cystic echinococcosis: long-term follow up of 52 patients. Ann Trop Med Parasitol 86:249–256
Bekesi JG, Tsang PH, Wallace J, Roboz JP (1987) Immunoreactive properties of isoprinosine in the treatment of patients at high risk of developing ARC or AIDS. J Clin Lab Immunol 24:155–161
Chappell LH (1988) The interactions between drugs and the parasite surface. Parasitology 96: 167–193
Constantine CC, Lymbery AJ, Thompson RCA, Obendorf DL (1991) The origin of a new focus of infection withEchinococcus granulosus in Tasmania. Int J Parasitol 21:959–961
Craig S, Deshan L, Zhaosain D (1991) Hydatid disease in China. Parasitol Today 7:46–50
Delabre-Defayolle I, Sarciron ME, Audin P, Gabrion C, Duriez T, Paris J, Petavy AF (1989)Echinococcus multilocularis metacestodes: biochemical and ultrastructural investigations on the effect of isatin (2–3 indoline dione) in vivo. J Antimicrob Chemother 23:237–245
De Rosa F, Teggi A (1990) Treatment ofEchinococcus granulosus hydatid disease with albendazole. Ann Trop Med Parasitol 84:467–472
Duriez T, Depreux P, Thuillier P, Afchain D, Marcincal A, Deblock S (1992) Potential anti-echinococcal activity of alklaminoethers. Parasitol Res 78:60–65
Eckert J (1986) Prospects for treatment of the metacestode stage ofEchinococcus. In: Thompson RCA (ed) The biology ofEchinococcus and hydatid disease. George Allen & Unwin, London, pp 250–277
Eckert J, Ammann R (1990) Information zum sogenannten Fuchsbandwurm. Schweiz Arch Tierheilkd 132:92–98
Ergüney S, Tortum O, Haydar A, Taspinar, Ertem M, Gazioglu E (1991) Les kystes hydatiques compliqués du foie. Ann Chir 45:584–589
Furuya K, Nishizuka M, Honma H, Kumagai M, Sato N, Takahashi M, Uchino J (1990) Prevalance of human alveolar echinococcosis in Hokkaido as evaluated by Western blotting. Jpn J Med Sci Biol 43:43–49
Grisi L (1990) Parasitic zoonses: selective review of some diseases in South America. Ann Parasitol Hum Comp 65:79–82
Hope M, Bowles J, Prociv P, McManus D (1992) A genetic comparison of human and wildlife isolates ofEchinococcus granulosus in Queensland: public health implications. Med J Austr 156:27–30
Horton RJ (1989) Chemotherapy ofEchinococcus infection in man with albendazole. Trans R Soc Trop Med Hyg 83:92–107
Marchiondo AA, Andersen FL (1985) In vivo efficacy and ultrastructural effects of mitomycin C against experimental alveolar hydatid disease. J Helminthol 59:29–38
Miyaji S, Katakura K, Matsufuji S, Murakami Y, Hayashi S, Oku Y, Okamoto M, Kamiya M (1993) Failure of treatment with alpha-difluoromethylornithine against secondary multilocular echinococcosis in mice. Parasitol Res 79:75–76
Novak M (1990) Efficacy of mitomycin C against alveolarEchinococcus. Int J Parasitol 20:119–120
Pedersen C, Sanstrom E, Pedersen CS, Norkraus G (1990) The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. N Engl J Med 322:1757–1763
Petavy AF, Deblock S, Walbaum S (1991) Life cycles ofEchinococcus multilocularis in relation to human infection. J Parasitol 77:133–137
Rausch RL (1986) Life-cycle patterns and geographic distribution ofEchinococcus species. In: Thompson RCA (ed) The biology ofEchinococcus and hydatid disease. George Allen & Unwin, London, pp 44–80
Richards KS, Morris DL, Daniels D, Riley EM (1988)Echinococcus granulosus: the effects of praziquantel in vivo and in vitro on the ultrastructure of equine strain murine cysts. Parasitology 96:323–336
Sarciron ME, Delabre I, Walbaum S, Raynaud G, Petavy AF (1992) Effects of multiple doses of Isoprinosine onEchinococcus multilocularis metacestodes. Antimicrob Agents Chemother 36:191–194
Sarciron ME, Walbaum S, Arsac C, Raynaud G, Petavy AF (1993)Echinococcus granulosus: Isoprinosine treatment of the metacestode stage. Am J Trop Med Hyg 48:658–665
Schantz PM, Van denBossche H, Eckert J (1982) Chemotherapy for larval echinococcosis in animals and humans: report of a workshop. Z Parasitenkd 67:5
Steiger U, Cotting J, Reichen J (1990) Albendazole treatment of echinococcosis in humans: effects of microsomal metabolism and drug tolerance. Clin Pharmacol Ther 47:347–353
Taylor DH, Richards KS, Morris DL (1989) Rapid recovery ofEchinococcus granulosus following ‘successful’ albendazole therapy in a gerbil model. J Helminthol 63:349–352
Thompson RCA (1986) Prospects for treatment of the metacestode stage ofEchinococcus. In: Thompson RCA (ed) The biology ofEchinococcus and hydatid disease. George Allen & Unwin, London, pp 250–284
Todorov T, Mechkov G, Vutova K, Georgiev P, Lazarova I, Tonchev Z, Nedelkov G (1992) Factors influencing the response to chemotherapy in human cystic echinococcosis. Bull WHO 70:347–358
Vanparijs O (1990) Chemotherapy of experimentalEchinococcus multilocularis in jirds. Parasitol Res 76:238–240
WHO (1984) Guidelines for surveillance, prevention and control of echinococcosis/hydatidosis. WHO, Geneva
Wilson JF, Rausch RL, McMahon BJ, Schantz PM, Trujillo DE, O'Gorman MA (1987) Albendazole therapy in alveolar hydatid disease: a report of favorable results in two patients after short-term therapy. Am J Trop Med Hyg 37:162–168
Witassek F, Burkhard B, Eckert J, Bircher J (1981) Chemotherapy of alveolar echinococcosis. Eur J Clin Pharmacol 20:427–433
Xu XY, Liance M, Lin YG, Li WX, Houin R (1992) L'échinococcose alvéolaire en Chine: données acutuelles. Bull Soc Pathol Exot Filiales 85:241–246
Yasawy MI, El Shiekl MAR, Al-Karawi MA (1992) Albendazole in hydatid disease: results in 22 patients. Ann Saudi Med 12:152–156
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Elisabeth Sarciron, M., Walbaum, S. & Petavy, A.F. Effects of isoprinosine onEchinococcus multilocularis andE. granulosus metacestodes. Parasitol Res 81, 329–333 (1995). https://doi.org/10.1007/BF00931540
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00931540